^
    Back
    Association details:
    Biomarker:TBX1 overexpression
    Cancer:Cervical Cancer
    Drug:cisplatin (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    New
    Source:
    Bioengineered
    Title:

    T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways

    Excerpt:
    ...cell apoptosis and chemosensitivity to cisplatin were promoted in TBX1-overexpressing CC cells.
    DOI:
    10.1080/21655979.2021.1880732